Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
News
Advertisement
ACT December 2011 BPA Statement
Advertisement
Over the past year and a half we have been monitoring the trend towards adoption of risk-based monitoring across the industry, and in particular the move towards reduced source document verification (SDV).
Advertisement
GLOBAL TRIALS : Is Guatemala the Next Research Hotspot? SITES : Trials in Limited Resource Settings Also in this issue : New User Fees, Declining European Trials, Low Trial Results Reporting, Risk-Based Approach to Monitoring
The responsibilities regarding CV safety for drug developers are constantly evolving.
Tufts Center for Drug Development
Often CNS trial subjects face unique obstacles like mental dependency
Examining the challenges and solutions to the implementation of trials in resource-limited settings.
A case study of how cardiac safety assessments can be enhanced with Holter Bin.
Why biotechs need to use a more systematic approach and catch up with pharma.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
3
Adaptive Trial Design as a Pathway to Faster Development
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
